Company / Cash & Equivalents
InnovAge Holding Corp. Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$64.1M
FY2025
5-year range
$56.9M / $201.5M
FY2021-FY2025
Trend
+12.6%
vs FY2024
Sector context
#130 of 152
Health Care
What the data says
InnovAge Holding Corp.'s cash & equivalents of $64M is lower than 86% of companies in the Health Care sector (FY2025). Cash & Equivalents returned to growth in FY2025 after 3 years of decline, reaching $64M.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of -10.7%.
Declined from $127M to $64M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -29.7%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 152This company $64.1M Sector average $1.2B
▼
-94.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.7%, indicating a declining trend.
- In FY2025, cash & equivalents increased 12.6% year-over-year.
- Ranks #130 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $64.1M | +12.6% |
| FY2024 | $56.9M | -55.2% |
| FY2023 | $127.2M | -31.0% |
| FY2022 | $184.4M | -8.5% |
| FY2021 | $201.5M | +78.4% |
| FY2020 | $112.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026